Helle Fabricius Wöldike

Title: Helle Fabricius Wöldike: Innovator in Biotechnology

Introduction

Helle Fabricius Wöldike is a notable inventor based in Måløv, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of novel strains and peptides. With a total of 4 patents, Wöldike's work has the potential to impact various applications in medicine and research.

Latest Patents

Wöldike's latest patents include a novel non-pathogenic B BL21 strain, which comprises a deletion of the group II capsular gene cluster. This invention is aimed at enhancing the production of peptides. Another significant patent involves IL-21 derivatives and variants, which provides methods for producing such variants, along with new variants of IL-21 and various methods of utilizing these molecules.

Career Highlights

Throughout his career, Wöldike has worked with prominent companies in the biotechnology sector, including Novo Nordisk A/S and Novozymes A/S. His experience in these organizations has allowed him to develop innovative solutions that address critical challenges in the industry.

Collaborations

Wöldike has collaborated with several professionals in his field, including Christine Bruun Schiødt and Jianhui Deng. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Helle Fabricius Wöldike is a distinguished inventor whose work in biotechnology continues to pave the way for innovative solutions. His contributions, particularly in the area of peptide production and IL-21 variants, highlight the importance of research and collaboration in advancing scientific knowledge.